Pharmacokinetics and antitumor activity of a new platinum compound,cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl- 1, 3-dioxolane]platinum(II), as determined by ex vivo pharmacodynamics Dae-Kee KimHun-Taek KimWeon-Seon Hong Original Article Pages: 1 - 6
Comparative pharmacodynamic analysis of TAT-59 and tamoxifen in rats bearing DMBA-induced mammary carcinoma Toshiyuki TokoJiro ShibataEiji Matsushima Original Article Pages: 7 - 13
Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy Jean-Pierre SommadossiErika M. CrettonMahmoud H. el Kouni Original Article Pages: 14 - 22
Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts Anders JohnssonChristina OlssonEva Cavallin-Stahl Original Article Pages: 23 - 31
Intraperitoneal 5-fluoro-2′-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study Valerie K. IsraelChun JiangKenneth K. Chan Original Article Pages: 32 - 38
A phase I trial of 5-day continuous infusion cisplatin and interferon α Michael P. GoslandSusan GoodinWilliam J. John Original Article Pages: 39 - 46
Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation M. C. Launay-IliadisR. BrunoA. Iliadis Original Article Pages: 47 - 54
Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids Birgitta C. P. HüskenJan de JongAalt Bast Original Article Pages: 55 - 62
Antimicrotubule effects of the novel antitumor benzoylphenylurea derivative HO-221 Nobuaki AndoTsunetaka NakajimaShigeru Tsukagoshi Original Article Pages: 63 - 69
In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferation Øystein BruserudIngrid NesthusGraham Pawelec Original Article Pages: 70 - 78
A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin Ian N. OlverLorraine K. WebsterJames F. Bishop Original Article Pages: 79 - 85
A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal caner Malcolm J. MooreLeonard KaizerSheldon Fine Original Article Pages: 86 - 90
Pharmacokinetics of 4′-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer Robert M. MaderHarald ZilgChristian Dittrich Original Article Pages: 91 - 96
Long-term pharmacokinetic behavior of platinum after cisplatin administration Erick GamelinPierre AllainFrancis Larra Original Article Pages: 97 - 102
Accumulation of anthracenyl-amino acid topoisomerase I and II inhibitors in drug-sensitive and drug-resistant human ovarian cancer cell lines determined by high-performance liquid chromatography Jeffrey CummingsIan MeikleJohn F. Smyth Original Article Pages: 103 - 109
Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities M. Barberi-HeyobB. WeberF. Guillemin Original Article Pages: 110 - 116
Stability of the i.v. and oral formulations of etoposide in solution Simon P JoelPeter I ClarkMaurice L. Slevin Original Article Pages: 117 - 124
Pharmacological attempts to improve the bioavailability of oral etoposide Simon P JoelPeter I ClarkMaurice L Slevin Original Article Pages: 125 - 133
An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3 mg over 30 s in patients receiving chemotherapy for malignant disease James CarmichaelPhilip A. PhilipAdrian L. Harris Original Article Pages: 134 - 138
Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics Barbara A. ConleySusan O'HaraDavid A. Van Echo Original Article Pages: 139 - 149
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation Gerrit LosFrank A. BlommaertStephen B. Howell Original Article Pages: 150 - 154
Dosing of thioTEPA for myeloablative therapy Donna PrzepiorkaTimothy MaddenMeletios Dimopoulos Original Article Pages: 155 - 160
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer Michael J. MillwardDavid R. NewellA. Hilary Calvert Original Article Pages: 161 - 167
Collateral sensitivity to radiation and CIS-platinum in a multidrug-resistant human leukemia cell line Jonathan ChoYoung LeeLewis Slater Original Article Pages: 168 - 172
The distribution of systemically administered [3H]-paclitaxel in rats: a quantitative autoradiographic study Glenn J. LesserStuart A. GrossmanEric K. Rowinsky Original Article Pages: 173 - 178
Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment Olivier PauwelsRobert Kiss Original Article Pages: 179 - 186
Functional expression of the renal organic cation transporter and P-glycoprotein inXenopus laevis oocytes J. Arly NelsonAnuradha DuttDavid A. Wright Original Article Pages: 187 - 189
High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer J. T. KamphuisM. C. HuiderJ. T. M. Burghouts Clinical Trial Report Pages: 190 - 192
Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R )-4,5-bis(aminomethyl)-2-isopropyl- 1, 3-dioxolane]platinum(II), as determined by ex vivo pharmacodynamics D.-K. KimH.-T. KimWeon-Seon Hong ORIGINAL ARTICLE Pages: 1 - 6
